
Mar 8, 2025, 10:56
Myeloma Paper of the Day, March 8th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Octogenarian myeloma patients have more comorbidities, higher Charlson comorbidity scores, lower rates of anti-MM therapy, reduced triplet/quadruplet use, and shorter median OS, while daratumumab positively influenced outcomes.”
Authors: Dor Shpitzer, Yael Cohen, Tamir Shragai, Ori Grossberger, Dana Amsterdam, Anat Reiner-Benaim, Irit Avivi.
More posts featuring Robert Orlowski.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 6, 2025, 06:18
Apr 6, 2025, 06:01
Apr 6, 2025, 05:46
Apr 6, 2025, 05:33
Apr 6, 2025, 05:06